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A T Cell Receptor CDR3 Loop Undergoes
Conformational Changes of Unprecedented Magnitude
Upon Binding to a Peptide/MHC Class I Complex
actions. Low-affinity values (KD  1–90 M at 25C) were
reported for agonistic pMHC ligands and resulted from
both slow kon and fast koff values. The changes in heat
capacity and entropy revealed by thermodynamic analy-
sis of TCR/pMHC interactions further suggested that
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1Laboratoire de Cristallographie et the TCR and/or pMHC have flexible binding surfaces
that are stabilized upon complexation (Willcox et al.,Cristalloge´ne`se des Prote´ines
Institut de Biologie Structurale J.-P. Ebel 1999; Boniface et al., 1999). These data are congruent
with X-ray analyses of the bound and free forms of theCEA-CNRS-UJF
41, rue Jules Horowitz 2C TCR showing that two of its CDRs had undergone
conformational adjustments upon binding to the pMHCF-38027 Grenoble Cedex 1
2 Centre d’Immunologie de Marseille-Luminy surface (Garcia et al., 1998). The 2C TCR possesses
rather short CDR3s (CDR3, 7 residues; CDR3, 6 resi-INSERM-CNRS-Universite´ de la Mediterrane´e
Parc Scientifique de Luminy dues), and one could expect that longer CDR3s will
undergo concerted movements and/or conformationalCase 906
F-13288 Marseille Cedex 9 changes of even higher magnitude to dock onto the
pMHC surface. In this respect, the KB5-C20 TCR consti-France
tutes an extreme case since it possesses an eight resi-
due long CDR3 and a thirteen residue long CDR3 that
lies at the upper end of the size distribution observedSummary
for TCR  chain CDR3s (Pannetier et al., 1993; Rock et
al., 1994). In the absence of a pMHC ligand, the KB5-C20The elongated complementary-determining region
(CDR) 3 found in the unliganded KB5-C20 TCR pro- CDR3 and CDR3 loops rise above the plane formed by
the remaining CDRs (Housset et al., 1997) and give risetrudes from the antigen binding site and prevents its
docking onto the peptide/MHC (pMHC) surface ac- to a configuration that is incompatible with a diagonal
mode of docking on the pMHC surface. On the basis ofcording to a canonical diagonal orientation. We now
present the crystal structure of a complex involving those results, we inferred either that major conforma-
tional changes of the KB5-C20 CDR3 loop were re-the KB5-C20 TCR and an octapeptide bound to the
allogeneic H-2Kb MHC class I molecule. This structure quired for binding to pMHC according to a canonical
mode or that the KB5-C20 TCR would bind to the pMHCreveals how a tremendously large CDR3 conforma-
tional change allows the KB5-C20 TCR to adapt to surface with a previously unreported geometry. The allo-
reactive KB5-C20 T cell clone derives from H-2k micethe rather constrained pMHC surface and achieve a
diagonal docking mode. This extreme case of induced and recognizes three distinct peptides (pKB1, 2, and 3)
bound to the H-2Kb allogeneic MHC class I moleculefit also shows that TCR plasticity is primarily restricted
to CDR3 loops and does not propagate away from the (Guimezanes et al., 2001). We have determined and re-
fined to 2.7 A˚ resolution the structure of the KB5-C20 TCRantigen binding site.
single chain Fv fragment (scFv) in complex with H-2Kb
molecules loaded with one (pKB1:KVITFIDL) of the threeIntroduction
naturally processed octapeptides recognized by the
KB5-C20 TCR. We also present the 2.30 A˚ structure ofThe specificity of T cell recognition is determined by the
variable (V) domain of the T cell receptor (TCR)  and  the pKB1/H-2Kb binary complex, which, along with the
2.6 A˚ structure of the unliganded KB5-C20 TCR (Houssetchains. Crystallographic studies of TCR/peptide/MHC
(pMHC) class I complexes indicate a common diagonal et al., 1997), allowed us to determine whether major
structural reorganizations occur in the TCR and/or thedocking mode that maximizes interaction of the TCR
with the pMHC surface (2C/dEV8/H-2Kb, Garcia et al., pMHC upon complexation.
1998; A6/Tax/HLA-A2, Garboczi et al., 1996; B7/Tax/
HLA-A2, Ding et al., 1998). As shown by the crystal Results
structure of the BM3.3/pBM1/H-2Kb complex (Reiser et
al., 2000), this similarity in binding mode extends to Overview of Crystal Structures of KB5-C20/pKB1/
allorecognition, the ability for self-MHC-restricted TCRs H-2Kb and pKB1/H-2Kb
to crossreact with allelic variants of self-MHC molecules Two KB5-C20/pKB1/H-2Kb complexes are contained in
and to cause graft rejection and graft-versus-host the asymmetric unit (see Experimental Procedures).
disease. Their VV/peptide/MHC12 components can be per-
The ability to engineer soluble TCR and pMHC mole- fectly superimposed (rms difference of 0.35 A˚), and when
cules has led to the characterization of the kinetic and such superimposition is done, the two complexes only
thermodynamic parameters of a few TCR-pMHC inter- differ by a 6 rotation in the 3/2-M membrane-proxi-
mal domains. As shown in Figure 1, the KB5-C20 TCR
assumes a diagonal orientation relative to the long axis3 Correspondence: bernardm@ciml.univ-mrs.fr (B.M.), housset@
lccp.ibs.fr (D.H.) of the MHC peptide binding groove that is similar to
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sites. A well-defined electron density allowed building
of ordered carbohydrate chains for three of the four sites
present in the asymmetric unit. One N-acetylglucos-
amine (GlcNAc) bound to the Asn82 side chain is present
in both scFv models. For one of the V domains, a rather
long carbohydrate chain (GlcNAc1→ GlcNAc2→ Man1
[mannose] → Man2 → GlcNAc3 → Gal [galactose] →
Sia [N-acetylneuraminic acid] Man1 → Man3) could be
modeled at the glysosylation site found at position
Asn21 (Figure 1). This carbohydrate adduct results from
the biosynthesis of the KB5-C20 scFv in mouse my-
eloma cells and is clearly involved in crystal packing
since seven hydrogen bonds connect sugar rings with
a symmetry-related MHC molecule.
The structure of the unliganded pKB1/H-2Kb binary
complex is very similar to pMHC class I complexes for
which crystal structures have been determined (re-
viewed in Maenaka and Jones, 1999). Its comparison
with an OVA/H-2Kb structure (Fremont et al., 1995)
shows very similar peptide binding domains (rms differ-
ence of 0.39 A˚) and a 12 rotation of the 3/2-M do-
mains.
The two crystallographically independent KB5-C20/
pKB1/H-2Kb interfaces contain either three or six water
molecules, only one (bridging Thr4p and Asp99) being
conserved in both interfaces. Except for the BM3.3/
pBM1/H-2Kb complex that possesses a large pocket
Figure 1. Structure of the KB5-C20/pKB1/H-2Kb Complex at the V/pMHC interface filled with about 30 water
Backbone ribbon representation of the ternary complex showing molecules, other TCR/pMHC complexes resemble KB5-
the overall orientation of the KB5-C20 scFv TCR onto pKB1 bound C20/pKB1/H-2Kb in that either no (A6/Tax/HLA-A2 and
to the H-2Kb MHC molecule. Domains are color coded as follows:
B7/Tax/HLA-A2) or only a few (2C/dEV8/H-2Kb) waterTCR V, light red; TCR V, light blue; H-2Kb 1 domain, green; H-2Kb
molecules have been reported to be trapped at the TCR/2 domain, light purple; H-2Kb 3 domain, pink; 2-microglobulin,
pMHC interface.dark purple. The CDR1 and CDR2 loops from both V domains are
drawn as green and red coils, respectively. CDR3 is depicted in
dark blue, and CDR3 in light blue. The pKB1 is shown in yellow TCR-Peptide Interactions
and in a ball-and-stick format, with the N-terminal end on the left The KB5-C20 TCR interacts with the pKB1 peptide via
and C-terminal end on the right. Only one of the two complexes in
its CDR3, CDR1, CDR2, and CDR3 loops (Figurethe asymmetric unit of the crystal is shown. Also shown is the
2). When compared to other TCR/pMHC structures, thecarbohydrate chain that could be modeled at the Asn21 glycosyla-
number of interactions between KB5-C20 and pKB1 istion site.
rather limited (Table 1). These interactions involve most
of the accessible peptide amino acids (P2, P4, P6, and
P7). Side chain-dependent interactions consist of a hy-those of TCR/pMHC complexes for which crystal struc-
drogen bond at position P4, a hydrophobic contact withtures have been determined (Garboczi et al., 1996; Gar-
position P6, and an ionic interaction at position P7, andcia et al., 1998; Ding et al., 1998; Reinherz et al., 1999;
suggest that the KB5-C20 TCR has a smaller degree ofReiser et al., 2000; Hennecke et al., 2000). The KB5-C20
peptide permissiveness than the one postulated for theTCR binding angle to pKB1/H-2Kb differs by rotations
BM3.3 alloreactive TCR (Reiser et al., 2000).of 7.5 and 19.0 from those observed for the 2C/dEV8/
H-2Kb and BM3.3/pBM1/H-2Kb complexes, respectively.
Moreover, when compared to the 2C/dEV8/H-2Kb com- Conformational Changes upon TCR-pMHC
Associationplex, the footprint of the KB5-C20 TCR on the pMHC is
globally translated by 4 A˚ toward the N terminus of the To date, the analysis of the extent of conformational
changes that occur during TCR/pMHC binding has beenbound peptide, whereas that of the BM3.3 TCR is shifted
by approximately 3 A˚ toward the C terminus of the bound feasible only for the 2C TCR, using free and bound struc-
tures (Garcia et al., 1998), and to a lesser extent for thepeptide. The total surface area buried in the KB5-C20/
pKB1/H-2Kb interface (1000 A˚2 for each partner) is simi- D10 TCR, using the crystal structure of the D10/CA/I-Ak
MHC class II complex (Reinherz et al., 1999) and thelar to those of the A6/Tax/HLA-A2, B7/Tax/HLA-A2,and
2C/dEV8/H-2Kb complexes. All of the KB5-C20 TCR structure of the uncomplexed D10 scFv solved by nu-
clear magnetic resonance spectroscopy (Hare et al.,CDRs contribute to this interface (Table 1). In contrast
to the situation observed in the other reported TCR/ 1999). Comparisons of the KB5-C20/pKB1/H-2Kb,
pKB1/H-2Kb, and KB5-C20/De´sire´-1 Fab (Housset et al.,pMHC complex involving an alloreactive TCR (Reiser et
al., 2000), the KB5-C20 V and V domains contribute 1997) structures allow us to determine the range of
structural changes that happens during the binding ofevenly to the buried surface area.
The KB5-C20 TCR scFv contains two glycosylation a TCR having an unusually long CDR3. In the crystal
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Table 1. Intermolecular Contact between KB5-C20 TCR and pKB1/H-2Kb pMHC Complex
Hydrogen Bonds
KB5-C20 H-2Kb KB5-C20 pKB1
D26 OD1 NH1 R62 Q95 NE2 O V2
D26 OD1 NH2 R62 R50 NH1 OD2 D7
Y94 OH NE R62 R50 NH2 OD2 D7
Q95 OE1 NZ K66 D99 OD1 OG1 T4
R101 NZ OE1 Q65
R101 NZ O Q65 T28 OG1 Wat NZ K1
Q29 OE1 O K146 Q95 N Wat NZ K1
Q29 OE1 N A150 D99 OD1 Wat OG1 T4
S51 OG OE1 Q72
D54 OD1 OE1 Q72
Vdw Contacts
KB5-C20 H-2Kb Nb of Cont. KB5-C20 pKB1 Nb of Cont.
R50 A158 2 P30A D7 1
Y94 R62 10 A96 I6 2
Q95 T163 3 A97 T4, I6 1, 1
K66 1 P98 T4 1










Distance cutoffs used are 3.65 A˚ for hydrogen bonds and 4.5 A˚ for van der Waals contacts. The angle cutoff used for hydrogen bonds is 90.
Italicized characters denote interactions present in only one of the two TCR-pMHC complexes found in the asymmetric unit. The water
molecules that form hydrogen bond bridges between the TCR and the pKB1 peptide are also listed.
structure of a complex between KB5-C20 and the spe- 1999) contrasts with the dense network of contacts be-
tween the KB5-C20 CDR3 loop and residues elsewherecific anti-clonotypic antibody De´sire´-1 (Housset et al.,
1997; Mazza et al., 1999), the single contact between in the V and V domains (see Supplemental Table S1
at http://www.immunity.com/cgi/content/full/16/3/345/the KB5-C20 CDR3 loop and De´sire´-1 (Mazza et al.,
Figure 2. Stereoscopic Views of Antigenic
Peptide Read-Out by TCRs Specific for H-2Kb
The MHC 1 helix is shown depicted in the
background as a green cylinder. The CDRs
of the KB5-C20, BM3.3, and 2C TCRs are
represented as thin worms, using the same
color code as in Figure 1. Hydrogen bonds
are represented as red and/or blue dotted
lines, van der Waals contacts as gray ones,
and long-range electrostatic interactions as
white ones. Despite the fact that the three
TCRs bind to the same MHC molecule, they




However, the number of contacts stabilizing the two
CDR3 conformations is almost identical, and the salt
bridge connecting Arg93 with Glu105 is conserved in
both structures. Based on the analysis of the 2C (Garcia
et al., 1998), D10 (Hare et al., 1999), and KB5-C20 (this
paper) TCRs, flexibility appears to be unevenly distrib-
uted over the binding site; major conformational reorga-
nizations are limited to CDR3s, whereas CDR1 and
CDR2 loops are the object of only minor hinge motions
and of rearrangements of the side chains corresponding
to surface residues.
Upon complexation to pKB1/H-2Kb, the KB5-C20 TCR
Figure 3. Superimposition of the Liganded and Unliganded KB5- also undergoes changes in V/V pairing (the Vdomain
C20 TCR Antigen Binding Site
being rotated by 8.7 relative to the V domain, see
This view looks directly into the antigen binding site and shows the
Supplemental Table S2 at http://www.immunity.com/cgi/large conformational change that CDR3 undergoes upon docking
content/full/16/3/345/DCI) and in the pseudo 2-fold rota-to the pMHC. The backbone structure of the TCR is represented as
tion relating V to V (175 in KB5/Desire´-1 versus 166thick tubes. The color scheme is the same as in Figure 1, except
that the liganded and unliganded forms are depicted in lighter and in KB5/pKB1/H-2Kb). This change in pairing induces a
darker colors, respectively. shift in the relative positions of the CDR1 and CDR2
apices that does not exceed 1 A˚, while the network of
hydrophobic interactions found at the core of the V/DCI). Therefore, the CDR3 configuration observed in
V interface remains almost unchanged. In the case ofthe KB5-C20/De´sire´ 1 complex (Figure 3) is likely to
the 2C TCR, the difference in V/V pairing is only of 4constitute an integral structural property of the unli-
and thus close to the range of intrinsic variability foundganded KB5-C20 TCR and does not seem to result from
for V/V pairing. For instance, comparison of the V/its limited interaction with De´sire´-1.
V pairing angle of the two complexed KB5-C20 TCRsOn the pMHC side, superimposition of pKB1/H-2Kb
present in the asymmetric unit showed that they alreadyonto its TCR bound form shows that the conformations
differ by 2. The rearrangement in VL/VH pairing thatof both the H-2Kb molecule and the peptide are very
occurs upon antibody/protein antigen binding are ofwell conserved upon complexation. An rms difference
similar magnitude (0.7–8.2 range) and contrary to previ-of 0.35 A˚ is found for the H-2Kb peptide binding domain,
ous hypotheses (Colman, 1988; Stanfield et al., 1993)and only a 6 rotation is observed in the relative orienta-
do not appear to depend on the extent of the VL/VHtion of the 3 and 2-M domains. The main conforma-
interface (see Supplemental Table S2 at http://www.tional changes are limited to the side chains of the up-
immunity.com/cgi/content/full/16/3/345/DCI). In both 2Cward-pointing MHC -helical residues Arg62kb, Gln65kb,
and KB5-C20, complexation to the pMHC is associatedGln72kb, and Lys146kb that are in contact with the TCR.
with a decrease in the surface of the V/V interface.At the level of the pKB1 peptide, the main difference
This drop is mainly due to CDR3 (KB5-C20) or CDR3corresponds to a 120 rotation of the side chain of resi-
(2C) rearrangements. It is of similar magnitude (100 A˚2)due Thr4p that allows the interaction of its hydroxyl group
in both V/V interfaces and thus does not appear towith the carboxyl group of Asp99 (see Supplemental
have a direct impact on the extent on V/V quaternaryMovie S1 at http://www.immunity.com/cgi/content/full/
rearrangements.16/3/345/DCI).
On the TCR side, if the CDR3 loop is left out, only
small rms differences are found between the liganded
Discussionand unliganded KB5-C20 V domains (0.57 A˚ for V, and
0.64 A˚ for V), illustrating the structural stability of the V
Difference in Three TCR-H-2Kb Interfacesdomain framework and of the CDR1, CDR2, and CDR3
The 2C, BM3.3, and KB5-C20 TCRs recognize distinctloops. While the unliganded CDR3 had an elongated
peptides bound to H-2Kb. In spite of a similar diagonalconformation with a tip made of a five residue turn corre-
mode of docking, these three TCRs differ extensively insponding to positions 99–103, the liganded CDR3
their binding angle, the surface area they bury, and theadopts a novel S-shaped conformation made of two
atomic interactions they establish. Although the sametype I  turns (Figure 3), one of them being located
13 MHC residues are buried by the three TCRs, onlyin the peptide binding groove and pointing toward the
four of them contact the same CDR loop in the threepeptide N terminus (residues 97–100) and the other
complexes (Arg62kb/CDR1, Val76kb/CDR2, Arg155kb/on the crest of the 2 MHC helix (residues 101–104,
CDR3, and Ala158kb/CDR2). Moreover, the detailedFigure 1). Large rms deviations (see Supplemental Table
atomic features of each of these topologically conservedS2 at http://www.immunity.com/cgi/content/full/16/3/
interactions are very different. Therefore, consistent with345/DCI) emphasize that the CDR3 conformational
a previous comparison involving the A6/HLA-A2 andchanges involve both a positional shift (15.1 A˚ shift for
B7/HLA-A2 complexes (Ding et al., 1998), there is nothe apex) and a dramatic structural reorganization. As
evidence for the existence of conserved binding fea-a result, most of the interactions stabilizing the unbound
tures in the three known TCR-H-2Kb interfaces, and theCDR3 conformation are no longer present in the bound
overall similarity in H-2Kb binding mode is achieved with-conformation (see Supplemental Table S1 at http://
www.immunity.com/cgi/content/full/16/3/345/DCI). out using conserved atomic contacts.
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terminus of the MHC 1 helix, eliciting a different V
footprint on pMHC surface. Among the three (BM3.3)
to four (KB5-C20) CDR2 residues that contact H-2Kb,
Arg50 and Ser51 are used in the two complexes. In both
instances, Arg50 contacts MHC residue Val76kb via its
aliphatic chain, although in a rather different manner.
As shown in Figure 4, the footprint of the CDR1 loop
is even more different, involving residues of the H-2Kb
2 helix for KB5-C20 and residues of the H-2Kb 1 helix
for BM3.3. Therefore, the CDR1/CDR2 loop combina-
tion found in the product of a given V gene segment
does not adopt a unique solution to bind to a given MHC
surface.
Whether such a conclusion also applies to CDR1/
CDR2 combinations remains to be determined. TCR/
pMHC structures involving the same V gene segments
and the same MHC allele are not yet available to directly
address this question. However, both the D10 and KB5-
C20 TCRs use V gene segments that belong to the
same subfamily (V2). Even if they do not interact with
the same class of MHC molecules, their comparison
Figure 4. Docking of V2 and V2 Domains onto pMHC Ligands allows some glimpses at the conservation of V/MHC
interactions. As shown in Figures 4C and 4D, the D10The four views are looking directly onto the surface of the pMHC
complexes. In each one, the C terminus of the bound peptide is on and KB5-C20 CDR1/CDR2 loops contact the MHC
the right. The CDRs of the different TCRs are projected on the pMHC surface in very distinct manners. When the 1/2 do-
surface and are represented as thin worms using the same color mains of H-2Kb are superimposed onto the 1/1 do-
code as in Figure 1. The pMHC surfaces are color coded according
mains of I-Ak, the KB5-C20 CDR1/CDR2 loops areto the CDRs that contact them: CDR1-buried, green; CDR2-buried,
shifted by more than 10 A˚ toward the peptide N terminusred; CDR3-buried, blue. The MHC helices are visible through the
relative to that observed for D10. This difference in Vsemitransparent surface and colored in light emerald green (1) or
light purple (2 or 1). In (A) and (B), views represent the footprint footprints may result from the fact that they involve two
of the molecular surface of the KB5-C20 and BM3.3 V2 domains different classes of MHC molecules and/or that the cor-
on the pMHC solvent-accessible surface, respectively. In (C) and responding V associates with different CDR3 loops and
(D), views represent the footprint of the molecular surface of the
V domains. All CDR1/CDR2 loops clamp down on aKB5-C20 and D10 V2 domains on the pMHC solvent-accessible
region that is structurally well conserved between class Isurface, respectively.
and class II MHC molecules (see Hennecke et al., 2000).
Therefore, the existence of two classes of MHC mole-
cules does not appear to fully account for the variabilityDocking of TCR V Domains to pMHC Ligands
observed in CDR1/CDR2 docking. Given that eachWhether the product of each of the many V and V
CDR1/CDR2 loop combination may also adopt differ-gene segments adopts a unique binding mode toward
ent solutions for binding to a given MHC surface, it isa given MHC allele and accordingly fixes the overall
tempting to speculate that, within the framework of ageometry of TCR/pMHC interactions remains an un-
diagonal docking orientation, two TCRs bearing thesolved question. Comparison of the D10 TCR interaction
same VV combination (i.e., displaying the same con-with CA/I-Ak and of the 2C TCR interaction with dEV8/
stellation of CDR1 and CDR2 loops) and recognizingH-2Kb already showed that one V domain (V8.2) can
the same MHC allele will show binding interactions thatinteract very differently with class I and class II MHC
differ at the atomic level and depend on the nature ofmolecules (Reinherz et al., 1999). The A6 and B7 TCRs
the CDR3s loops they express. Finally, in the absencealso use the same V gene segment and bind to the
of any conserved TCR-MHC contact, the way TCRssame MHC allele. However, the presence of a 11 residue
achieve a canonical mode of docking onto the pMHClong CDR3 in the A6 TCR lifts the V CDR1 and CDR2
remains to be elucidated.loops over the MHC surface and prevents them from
contacting it (Ding et al., 1998). This precludes a proper
side by side comparison but already suggests that Peptide Recognition by KB5-C20
Comparison of the atomic structures known for CDR3CDR1 and CDR2 are unlikely to define a conserved
anchor on the pMHC surface. The comparison of the shows that the apex of those found in TCRs specific for
H-2Kb folds back toward the peptide N terminus andKB5-C20/pKB1/H-2Kb and BM3.3/pBM1/H-2Kb com-
plexes bears more directly on the above issue since thus maximizes the read-out of peptides that bind, in
an extended or slightly arched conformation, deep inboth TCRs use the same V2 gene segment and recog-
nize the same MHC allele. As depicted in Figures 4A the H-2Kb binding cleft (Figure 2 and Reiser et al., 2000).
On the other hand, the distinct CDR3 conformationand 4B, the KB5-C20/pKB1/H-2Kb and BM3.3/pBM1/
H-2Kb complexes show two markedly different modes found in the A6 and B7 TCRs seems better suited to
recognize peptides that, owing to their length or to theirof V2/H-2Kb interaction. When compared to the BM33/
pBM1/H-2Kb complex, the KB5-C20 CDR1 and CDR2 binding to much shallower MHC clefts, have more sub-
stantial bulges in their centers or at their C termini. Con-loops are shifted by approximately 7 A˚ toward the N
Immunity
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sistent with our previous observation (Reiser et al., TCRs do contact the allo-MHC surface with a register
similar to the one they used to contact the self-MHC2000), in the KB5-C20/pKB1/H-2Kb complex, the type I
 turn that is adopted by the CDR3 also points toward molecules responsible for their selection during intra-
thymic development. The KB5-C20/pKB1/H-2Kb struc-the peptide NH2 terminus and thereby interacts with
peptide residues at positions P4 and P6. ture conforts this conclusion in that the KB5-C20 TCR
contacts MHC -helical residues that are mostly con-Among the peptide residues buried by KB5-C20, three
correspond to polar (Thr4p) or charged (Lys1p, Asp7p) served between H-2Kb and H-2Kk (the self-MHC mole-
cule involved in KB5-C20 selection; Schonrich et al.,amino acids and are likely to play a significant role in
the KB5-C20/pKB1/H-2Kb interaction (Figure 2). Despite 1993). Among the H-2Kb residues contacted by the KB5-
C20 TCR, a single one differs in H-2Kk. It is located atits lack of direct contact with the TCR, the side chain
of the lysine found at P1 is fully buried at the interface position 66 and corresponds to a lysine in H-2Kb and to
an isoleucine in H-2Kk. As shown in Figure 5, Lys66kband can establish long-range electrostatic interactions
with OE1 Gln95 and OG1 Thr28, located at about 5 A˚ of forms hydrogen bonds with the side chain of Gln95 and
with the carbonyl group of Val2p and can be readily sub-NZ. This type of long-range interaction (more than 4 A˚)
may contribute significantly to the binding free energy stituted without any steric clash by an isoleucine. Con-
trasting with the observation that H-2Kb and H-2Kk look(Schreiber and Fersht, 1995). The interaction of CDR3
with both the Val2p main chain carbonyl group and the almost the same in terms of the residues sensed by the
KB5-C20 TCR, 14 out of the 29 residues forming theThr4p side chain constitutes another prominent feature
of the KB5-C20/pKB1 interaction. Finally, the salt bridge peptide binding groove differ between H-2Kb and H-2Kk
and allow two distinct repertoires of peptides to be dis-between Asp7p and Arg50 is the first ionic interaction
ever identified between a TCR and an MHC class I bound played by these two alleles (see legend of Figure 5, and
Rammensee et al., 1999). Therefore, the KB5-C20/pKB1/peptide. Such interactions have already been docu-
mented between a TCR and a peptide presented by an H-2Kb structure supports the assumption that self-MHC-
restricted TCRs do not undergo a global repositioningMHC class II molecule (Hennecke et al., 2000) as well
as between the TCR and the MHC surface (Garboczi et upon binding to an allo-pMHC surface and that the high
precursor frequency of alloreactive T cell clones resultsal., 1996; Garcia et al., 1998; Ding et al., 1998; Reiser et
al., 2000). Although ionic bond constitutes one of the from the fact that allogeneic MHC molecules display
a totally novel constellation of endogeneous peptidesstrongest interactions in protein-protein complexes, ac-
counting for about 3 to 6 kcal/mol (Fersht, 1972), salt against which the repertoire of mature T cells has not
been negatively selected in the thymus.bridge contributions to complex stability have been the
object of much debate over the past decade. For in-
stance, studies on antibody/antigen complexes have Canonical CDR1 and CDR2 Conformations
shown that the energy contribution of polar or ionic Based on the comparison of the atomic structures
interactions is tightly dependent on solvent accessibility known for V and for V domains, it has been proposed
(Dall’Acqua et al., 1998; Hawkins et al., 1993) and on that a given CDR1 (or CDR2) loop adopts a main chain
the extent of surface complementarity (Brummell et al., conformation that is both independent of the constella-
1993). In the KB5-C20/pKB1/H-2Kb complex, the Asp7p- tion of CDRs it associates with and is conserved on
Arg50 salt bridge is exposed to solvent and is present complexation to pMHC (Al-Lazikani et al., 2000). More-
in a local environment of rather low surface complemen- over, based on their length as well as on residues pres-
tarity. Those observed between the TCR and the MHC ent at key sites, the many CDR1 and CDR2 loops were
molecule (Garboczi et al., 1996; Garcia et al., 1998; Ding assigned to a small repertoire of main chain conforma-
et al., 1998; Reiser et al., 2000) are also accessible to tions called canonical structures (Al-Lazikani et al.,
solvent molecules. Therefore, the contribution of these 2000). Comparison of the main chain conformation of
salt bridges to the stabilization of the TCR/pMHC inter- the KB5-C20 CDR1 and CDR2 loops found in two distinct
action is likely to be reduced, corroborating the rather environments (the KB5-C20/pKB1/H-2Kb and the KB5-
low-affinity values reported for TCR-pMHC interactions. C20/De´sire´-1 complexes) supports the proposal that
However, by limiting the number of possible modes of CDR1 and CDR2 loops do not change their overall con-
interaction, their main role might be to enhance the formation on complex formation (Figure 3 and Supple-
specificity of the interaction as observed for other pro- mental Table S2 at http://www.immunity.com/cgi/
tein complexes (Souza et al., 1995; Sindelar et al., 1998). content/full/16/3/345/DCI). The only accommodative
changes are found among the residues that are exposed
at the surface of these loops and end up buried at theMolecular Basis of Alloreactivity
Although the KB5-C20/pKB1/H-2Kb crystal structure TCR-pMHC interface. For instance, some of the latter
have their side chains shifted by up to 6 A˚ relative toconstitutes only the second one involving an alloreactive
TCR, it allows some generalizations to be made con- their position in the free TCR. Al-Lazikani et al. (2000)
also pointed out that CDR3s show much greater variabil-cerning allorecognition. The structures of the KB5-C20/
pKB1/H-2Kb and BM3.3/pBM1/H-2Kb allocomplexes ity in length, sequence, and conformation than the other
CDRs and are thus not easily amenable to a classifica-show that both peptide and MHC residues are contacted
by the TCR and that the binding mode is like that of tion into canonical structures. Consistent with this pro-
posal, the tremendous conformational change observedTCRs in complex with self-MHC molecules. The BM3.3/
pBM1/H-2Kb structure (Reiser et al., 2000) and hypothet- for the KB5-C20 CDR3 upon pMHC binding illustrates
the difficulties in developing rules relating CDR3 se-ical molecular models constructed for other allocom-
plexes (Speir et al., 1998) suggested that alloreactive quences to canonical conformations.
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Figure 5. Stereoscopic View of the Peptide
Binding Groove of the pKB1/H-2Kb Binary
Complex
The pKB1 peptide is represented as a thick
yellow tube, the H-2Kb 1 domain in green,
and the H-2Kb 2 domain in purple. Hydrogen
bonds involving MHC residue Lys66kb are likely
to play a role in allorecognition and are shown
as dotted lines. MHC residues forming the
Phe5p binding pocket are represented in ball-
and-stick format. The side chains of H-2Kk
molecule have been modeled for positions 66
(Ile) and 97 (Arg) and are shown in orange
ball-and-stick format. The latter position is
likely to determine in part the peptide binding
specificity of H-2Kb and H-2Kk molecules. As
exemplified in the present model, peptides,
which like pKB1 have large side chain at posi-
tion P5, will collide with Arg97kk and thus be
excluded from the repertoire of peptides
binding to H-2Kk.
CDR Induced Fit upon pMHC Recognition the TCR constant domains. These observations are in-
consistent with TCR signaling models based on ligand-A comparison of the structures of the liganded and unli-
ganded 2C TCR shows that conformational readjust- induced propagation of conformational changes.
Upon complexation to antigens, antibodies also un-ments occur at the TCR/pMHC interface and correspond
primarily to en bloc movements of the CDR1 loop and dergo varying degrees of conformational changes that
occur both within and between V domains. Some anti-to a moderate conformational change of the CDR3 loop
leading to a 5.75 A˚ shift of its apex (Garcia et al., 1998; bodies exhibit very limited changes and interact with
their corresponding antigens according to a “lock-and-see Supplemental Table S2 at http://www.immunity.
com/cgi/content/full/16/3/345/DCI). These changes key” mechanism (Davies et al., 1988), whereas others
undergo adjustments in VL/VH pairing (Stanfield et al.,allow the side chain of peptide residue Lys4p to fit in the
enlarged pocket that resides between the CDR3 and 1993) and large CDR backbone movements, mainly in-
volving the CDR3s (reviewed in Wilson and Stanfield,CDR3 loops (Figure 2). Similar structural rearrange-
ments have been observed for the recognition of a su- 1994). For instance, changes resulting in a 16 A˚ shift of
a CDR apex (Fab CN5206, Charbonnier et al., 1995)peragonist peptide variant when an arginine replaces
lysine at position P4 (2C/SIYR/H-2Kb, Degano et al., or in a totally different CDR conformation (Fab 17/9,
Schulze-Gahmen et al., 1993) have been observed upon2000). In the case of the KB5-C20 TCR, the tremendous
structural reorganization of the KB5-C20 CDR3 loop antibody binding to hapten or peptide. However, com-
paring the extent of induced fit that occurs upon anti-that occurs upon complexation to the pMHC surface
allows it to evenly engage its V and V domains in the body/ligand and TCR/pMHC binding may appear more
appropriate when limited to protein antigen/antibodyinteraction with the pKB1/H-2Kb ligand and permits one
 turn of the CDR3 to contact the central region of the complexes. In that context (see Supplemental Table
S2 at http://www.immunity.com/cgi/content/full/16/3/peptide. This CDR3 conformation radically differs from
those adopted by the elongated CDR3 loops that are 345/DCI), the largest conformational change (4.4 A˚) is
noted for the distal tip of the CDR3H loop of antibodyalso found in the A6 and B7 TCR. In both the A6/Tax/
HLA-A2 and B7/Tax/HLA-A2 complexes, the CDR3 HC19 (Bizebard et al., 1995). Five antibodies exhibit mi-
nor shifts of CDR apices that are associated with sidepoints toward the peptide C terminus and forms a wedge
at the TCR/pMHC interface (Garboczi et al., 1996; Ding chain rearrangements (Bhat et al., 1990; Braden et al.,
1994; Huang et al., 1998; Li et al., 2000; Monaco-Malbetet al., 1998). These results show that the presence of
unusually long CDR3 neither prevents ligand recogni- et al., 2000), whereas no significant change was ob-
served for antibody E8 (Mylvaganam et al., 1998). Astion in an MHC-restricted way nor precludes docking
on the MHC according to the canonical diagonal orienta- observed for TCR/pMHC complexes, most antibody/
protein antigen complexes for which the crystal struc-tion. However, in contrast to virus-neutralizing antibod-
ies, in which the presence of extended CDR3 loops are tures of the free antibody and free ligand are available
display much larger local movements of the antibodyapparently favored to access canyons and clefts on viral
surfaces (Smith et al., 1996; Saphire et al., 2001), the binding site than of the epitope (Mylvaganam et al.,
1998). Therefore, the structural changes observed forpresence of extended CDR3 in TCR binding sites can
only be accommodated at the expense of large confor- the 2C TCR upon pMHC complexation fall within the
range of changes observed during antibody/protein an-mational changes that permit them to adapt to the rela-
tively flat pMHC surface. Moreover, in the case of the tigen binding, but in no instance has a conformational
reorganization of the magnitude noted for the KB5-C20KB5-C20 TCR, the large CDR3 rearrangement does
not propagate to the rest of the TCR antigen binding site, CDR3 yet been observed for antibodies upon complex-
ation with protein antigens.and the change noted in V/V pairing has no significant
effect on the conformation of the regions that contact The apparent lesser flexibility of antibody CDRs may
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containing 1.5M K2HPO4/N2HPO4 (pH 6.5) and 4.0 mg/ml of protein.originate from the fact that the conformational changes
The resulting crystal was transferred to a cryoprotectant solutionoccurring within a given antibody binding site depends
obtained by adding 35% v/v glycerol and flash cooled at 100 Kon its stage of maturation. To date, most crystallo-
under a nitrogen gas stream. The data set was collected at the
graphic studies have focused on antibodies resulting ESRF beamline ID14-eh3, using a 0.931 A˚ wavelength and a MarRe-
from secondary responses. However, as exemplified by search CCD detector. The crystal belonged to the monoclinic P21
space group, with a  61.2 A˚, b  90.6 A˚, c  89.6 A˚, and  Wedemayer et al. (1997) for an anti-hapten antibody, its
111.51, with two binary complexes per asymmetric unit. The 99.5%germline form undergoes large conformational changes
complete data set extends up to 2.3 A˚ resolution with an Rsym ofupon binding to the ligand, whereas its somatically hy-
0.046 and a redundancy of 3.3.permutated derivative has a 30,000-fold higher affinity
The KB5-C20/pKB1/H-2Kb ternary complex was formed 24 hr be-
and binds hapten via an entropically favorable lock-and- fore crystallization assays by mixing a solution of the KB5-C20 scFv
key mechanism. Considering that TCR genes are not TCR and a solution of the pKB1/H-2Kb binary complex at a 1 to 1
molar ratio and a final concentration of 4.0 mg/ml. The ternary com-subjected to somatic hypermutation and that, for at least
plex crystallized in the presence of 17%–19% PEG 6000, 0.1 M Messome TCR/pMHC interactions, the entropic penalties
(pH 6.7), 0.1 M NaCl, and 0.1 M MgAc. A data set was collected atassociated with complexation are in the range of those
the ESRF beamline BM30 (  0.987 A˚) on a single crystal cryopro-observed for germline antibody binding (Manivel et al.,
tected with 30% PEG6000 added to the mother crystallization solu-
2000), it is likely that induced fit constitutes a recurrent tion and flash cooled at 100 K. The data set had the following
feature of TCR/pMHC interactions that is used to im- characteristics: Rsym 0.084, completeness 96.9%, redundancy
3.4, and highest resolution  2.7 A˚. The ternary complex crystalprove the adaptation of the TCR to the rather conforma-
belongs to the P21 space group, with a  89.2 A˚, b  77.9 A˚, c tionally constrained pMHC surface.
133.0 A˚, and   108.2, and contains two complexes per asymmet-As far as the number of contacts between the KB5-
ric unit. Both data sets were processed with MOSFLM 6.1 (Leslie,C20 CDR3 loop and residues elsewhere in the V do-
1991) and SCALA of the CCP4 suite programs (Computational Pro-
mains are concerned, the unbound and pMHC-bound ject Number 4, 1994). Both structures were solved by molecular
CDR3 conformations appear almost equivalent (see replacement using AMoRe (Navaza, 1994). For the binary complex
structure, the OVA/H-2Kb crystal structure (Fremont et al., 1995) wasSupplemental Table S1 at http://www.immunity.com/
used as the starting model. For the ternary complex, we have usedcgi/content/full/16/3/345/DCI). Consistent with the acti-
the final model of pKB1/H-2Kb and the crystal structure of KB5-C20vation energy observed for TCR/pMHC association (Will-
scFv TCR solved in complex with the Fab De´sire´-1 (Housset etcox et al., 1999), our structural data indicate that the
al., 1997). Both final models were obtained after several rounds of
numerous interactions stabilizing the KB5-C20 CDR3 manual building using O (Jones et al., 1991) and refinement using
loop in its unbound state need to be disrupted prior REFMAC version 4.0 (Computational Project Number 4, 1994) for
pKB1/H-2Kb or CNS version 0.9a (Brunger et al., 1998) for KB5-to reengaging in the novel network of interactions that
C20/pKB1/H-2Kb against data in the range of 12.0 to the highestadopts the CDR3 loop in its pMHC-bound state. In that
resolution (2.3 A˚ and 2.7 A˚, respectively). Refinement cycles moni-last state, the CDR3 configuration is further stabilized
tored by the Rfree decrease were started with tight noncrystallo-by a significant numbers of contacts with the pMHC
graphic symmetry restraints that were released step by step during
(Table 1) that accounts for the general unfavorable en- the refinement process. The final model has been refined without
tropy contribution to TCR/pMHC interactions (Willcox noncrystallographic symmetry restraints.
Both final models show good refinement statistics. For pKB1/et al., 1999; Boniface et al., 1999; Garcia et al., 2001).
H-2Kb complex: Rcryst  21.1%, Rwork  20.7%, Rfree  25.9%, rmsBased on preliminary experiments, the affinity of KB5-
from ideality for bond distances  0.009 A˚, and rms from idealityC20 for pKB1/H-2Kb can be inferred to rank at the lower
bond angle  1.3. For KB5-C20/pKB1/H-2Kb complex: Rcryst end of the range reported for TCR-pMHC interactions 21.9%, Rwork  22.0%, Rfree  27.8%, rms from ideality for bond
(i.e., Kd104 M). This may result from a slow kon value, distances  0.009 A˚, and rms from ideality bond angle  1.6 (see
reflecting the fact that the KB5-C20 CDR3 loop exists Supplemental Table S3 at http://www.immunity.com/cgi/content/
full/16/3/345/DCI).in equilibrium between at least two discrete conforma-
When no significant differences are observed between the twotional states, only one being binding competent. Finally,
molecules of the asymmetric unit, the values given in the text areconsidering that the KB5-C20 TCR function largely de-
based on the A molecule. Accessible surfaces were calculated with
pends on the presence of the CD8 coreceptor, it would NACCESS using a 1.5 A˚ probe (Hubbard and Thornton, 1993), inter-
be interesting to test whether by favoring “lengthy colli- action distances with HBPLUS (McDonald and Thornton, 1994). Fig-
ures were generated with MOLSCRIPT 2.0 (Kraulis, 1991), RAS-sions,” CD8 increases the probability of generating a
TER3D (Merrit and Bacon, 1997), and the transparent surfaces usingcorrect complementarity between the TCR and pMHC
GRASP (Nicholls et al., 1991).interacting surfaces.
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